HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.
Also called NCT07233070
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 210 participants
- Registry
-
NCT07233070
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07233070. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-31 (actual); primary completion 2026-09-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- HRS-7450 Injection
- Intervention (Drug)
- HRS-7450 Injection
- Intervention (Drug)
- HRS-7450 Injection
- Intervention (Drug)
- HRS-7450 Injection Placebo
- Lead sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07233070- Content hash
a557166b9b541ea57879ee83a6aee09c7b04868d138832aba36b7c7b8472f5b2